A health monitoring center based in New York, USA for at-home physicians and nursing oversight companies has been working with LifeSignals since 2018 to broaden their services to skilled nursing facilities.
In 2016, LifeSignals partnered with a company based in Kerala, India that is transforming the way ambulatory cardiac monitoring is delivered and become the new normal among the leading cardiologists and neurologists in hospitals across the country.
An ambitious AI healthcare technology company based in Hyderabad, India approached LifeSignals in 2019 to take healthcare closer to consumers by utilizing the power of cloud technology.
A telehealth and cardiac screening company headquartered in Manila has been working with LifeSignals as of early 2020 to expand remote cardiac monitoring in the Philippines.
A leading Independent Diagnostic Testing Facility (IDTF), providing ambulatory cardiac monitoring services headquartered in New York, USA, came to LifeSignals in 2019 in search of a reliable, affordable, and FDA approved wireless biosensor that accurately captured and transmitted multi-channel ECG, for a real-time MCT application.
Further validation of ability to deliver continuous remote patient vital signs monitoring within both hospital and home settings.
LifeSignals receives CE Mark Approval for LifeSignals LX1550E Multiparameter Remote Monitoring Platform. Enables healthtech partners to deliver continuous remote patient vital signs monitoring within hospital and home settings.
LifeSignals Wireless Medical Biosensor LP1250 receives FDA clearance
World’s first single-use two channel ECG and heart rate biosensor provides 72- hour patient monitoring with remote data access in ambulatory, hospital and home settings
Continuous patient monitoring with remote data access in ambulatory, hospital and home settings enables faster clinical decision making
LifeSignals accelerates introduction of single-use wireless medical biosensor patches for COVID-19 mass population remote monitoring
